CCL2 is reported to directly induce PC cell line proliferation and migration in prostate cancer via phosphoinositide-3-kinase (PI3K)/serine-threonine kinase (Akt) signaling activation [16]. The gene discussed is CCL2; the disease is pachyonychia congenita.